Paravalvular leak will be one of the secondary endpoints in our early feasibility study.
And to follow-up on how confusing the different comparisons done by different companies, Dr Meduri in the webcast in Sept said for the 23mm valve, the Sapien is generally benchmarked at an EOA of 1.45 cm squared and the Evolut is about a 1.84, with the DurAVR at a 2. So it looks to me like the Abbott website is rounding up their numbers.Not sure if they rounded up their device but maybe they did and their actual EOA is below a 2 (provided that is for the 23 mm Abbott device, their website does not confirm that).
Paravalvular leak will be one of the secondary endpoints in our...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.98 |
Change
-0.140(2.29%) |
Mkt cap ! $92.99M | |||
| Open | High | Low | Value | Volume |
| $6.01 | $6.08 | $5.95 | $28.28K | 4.712K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $5.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.07 | 2710 | 2 |
View Market Depth
| Last trade - 13.16pm 26/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |